Our data suggest that intensive close monitoring of the onset of diabetes may not be necessary for people with incidentally identified pathogenic variants in HNF1A and HNF4A due to a substantially lower risk of diabetes. This evidence concerns the gene HNF4A and diabetes mellitus.